GMP “Design Space” To Facilitate FDA Quality Initiative Implementation
This article was originally published in The Pink Sheet Daily
Executive Summary
“Design Space” is emerging as a pivotal concept in FDA’s effort to integrate its pharmaceutical application review and inspection operations into a new “quality assessment” system. With regulatory flexibility for manufacturing changes in the balance, the agency will be working with industry to refine the concept and its application in drug development and manufacturing.